These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36136646)

  • 1. Efficacy of Fosfomycin against Planktonic and Biofilm-Associated MDR Uropathogenic
    Dzib-Baak HE; Uc-Cachón AH; Dzul-Beh AJ; Rosado-Manzano RF; Gracida-Osorno C; Molina-Salinas GM
    Trop Med Infect Dis; 2022 Sep; 7(9):. PubMed ID: 36136646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between antimicrobial resistance, biofilm formation, and virulence determinants in uropathogenic Escherichia coli from Egyptian hospital.
    Alshaikh SA; El-Banna T; Sonbol F; Farghali MH
    Ann Clin Microbiol Antimicrob; 2024 Feb; 23(1):20. PubMed ID: 38402146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of adhesin genes and risk factors associated with urinary tract infections by drug-resistant uropathogenic Escherichia coli in North of Iran.
    Sheikhi R; Amini ME; Alidoust L; Atrkar Roushan Z; Nikokar I
    J Infect Dev Ctries; 2024 May; 18(5):761-769. PubMed ID: 38865401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fosfomycin tromethamine activity on biofilm and intracellular bacterial communities produced by uropathogenic Escherichia coli isolated from patients with urinary tract infection.
    González MJ; Da Cunda P; Notejane M; Zunino P; Scavone P; Robino L
    Pathog Dis; 2019 Apr; 77(3):. PubMed ID: 31062019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biofilm formation by uropathogenic Escherichia coli: a complicating factor for treatment and recurrence of urinary tract infections.
    Naziri Z; Kilegolan JA; Moezzi MS; Derakhshandeh A
    J Hosp Infect; 2021 Nov; 117():9-16. PubMed ID: 34428502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of acute urinary tract infections caused by uropathogenic
    Pullanhi U; Khan S; Vinod V; Mohan K; Kumar A
    Ann Afr Med; 2019; 18(3):138-142. PubMed ID: 31417014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteriological and molecular study of fosfomycin resistance in uropathogenic Escherichia coli.
    Ibrahim AA; Mohammed RK
    Braz J Microbiol; 2024 Jun; 55(2):1091-1097. PubMed ID: 38367167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An
    Sugathan S; Mandal J
    J Med Microbiol; 2019 Dec; 68(12):1699-1706. PubMed ID: 31647407
    [No Abstract]   [Full Text] [Related]  

  • 9. Quinolone-resistant uropathogenic
    Sultan AM; Amer GF; Nabiel Y
    J Med Microbiol; 2021 Oct; 70(10):. PubMed ID: 34665111
    [No Abstract]   [Full Text] [Related]  

  • 10. Association of Virulence Markers With Resistance to Oral Antibiotics in Escherichia coli Isolates Causing Uncomplicated Community-Acquired Cystitis.
    Radera S; Agarwal J; Srivastava S; Gupta P; Pandey A
    Cureus; 2023 May; 15(5):e39458. PubMed ID: 37362452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between Biofilm-Production and Antibiotic Resistance in Uropathogenic
    Behzadi P; Urbán E; Gajdács M
    Diseases; 2020 Jun; 8(2):. PubMed ID: 32517335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High incidence of fosfomycin-resistant uropathogenic E. coli among children.
    Abdelraheem WM; Mahdi WKM; Abuelela IS; Hassuna NA
    BMC Infect Dis; 2023 Jul; 23(1):475. PubMed ID: 37460976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phylogenetic Group B2 Expressed Significant Biofilm Formation among Drug Resistant Uropathogenic Escherichia coli.
    Javed S; Mirani ZA; Pirzada ZA
    Libyan J Med; 2021 Dec; 16(1):1845444. PubMed ID: 33170767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A global systematic review and meta-analysis on correlation between biofilm producers and non-biofilm producers with antibiotic resistance in Uropathogenic Escherichiacoli.
    Garousi M; Monazami Tabar S; Mirazi H; Asgari P; Sabeghi P; Salehi A; Khaledi A; Ghenaat Pisheh Sanani M; Mirzahosseini HK
    Microb Pathog; 2022 Mar; 164():105412. PubMed ID: 35065252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enteroaggregative
    Martínez-Santos VI; Ruíz-Rosas M; Ramirez-Peralta A; Zaragoza García O; Resendiz-Reyes LA; Romero-Pineda OJ; Castro-Alarcón N
    PeerJ; 2021; 9():e11726. PubMed ID: 34513321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro effect of fosfomycin on multi-drug resistant gram-negative bacteria causing urinary tract infections.
    Gopichand P; Agarwal G; Natarajan M; Mandal J; Deepanjali S; Parameswaran S; Dorairajan LN
    Infect Drug Resist; 2019; 12():2005-2013. PubMed ID: 31372008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinolone resistance and biofilm formation capability of uropathogenic Escherichia coli isolates from an Iranian inpatients' population.
    Rastegar E; Malekzadegan Y; Khashei R; Hadi N
    Mol Biol Rep; 2023 Oct; 50(10):8073-8079. PubMed ID: 37540453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of genes encoding adhesins and biofilm formation capacity among Uropathogenic
    Kadry AA; Al-Kashef NM; El-Ganiny AM
    Afr Health Sci; 2020 Mar; 20(1):238-247. PubMed ID: 33402912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phylogenetic analysis, biofilm formation, antimicrobial resistance and relationship between these characteristics in Uropathogenic Escherichia coli.
    Talieh Mostaghimi ; Pournajaf A; Bijani A; Mohammadi M; Rajabnia M; Halaji M
    Mol Biol Rep; 2024 Feb; 51(1):327. PubMed ID: 38393446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro Investigation of Antibiotics Efficacy Against Uropathogenic
    Rafaque Z; Abid N; Liaqat N; Afridi P; Siddique S; Masood S; Kanwal S; Dasti JI
    Infect Drug Resist; 2020; 13():2801-2810. PubMed ID: 32848429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.